(S1 (S (S (NP (NN NF-kappaB) (NN activation)) (VP (VBZ potentiates) (NP (NP (DT the) (NN degree)) (PP (IN of) (NP (NP (NN IL-1beta) (NN production)) (CC and) (NP (NN secretion)))) (PP (IN upon) (NP (NN inflammasome) (NN activation)))))) (. .)))
(S1 (S (S (NP (NN THP-1) (NN reporter) (NNS cells)) (VP (VBD were) (VP (VP (VBN primed) (S (ADJP (JJ overnight) (PP (IN with) (NP (JJ heat-killed) (NP (FW P.) (FW aeruginosa))))))) (CC and) (VP (VBN stimulated) (NP (NP (DT the) (JJ next) (NN day)) (PP (IN with) (NP (JJ live) (NP (FW P.) (FW aeruginosa)) (CC or) (NP (JJ additional) (JJ heat-killed)) (NP (FW P.) (FW aeruginosa)))) (PP (IN for) (NP (NP (DT the) (NNS times)) (VP (VBD indicated))))))))) (. .)))
(S1 (S (S (NP (NN Cell) (NN culture) (NNS supernatants)) (VP (VBD were) (VP (VBN assayed) (PP (IN for) (NP (NP (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NN NF-kappaB/AP-1) (NN activity)) (, ,) (NP (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NN IL-8)) (, ,) (CC and) (NP (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (NN IL-1beta) (NN secretion) (PRN (-LRB- -LRB-) (S (NP (NN n)) (VP (JJ =) (NP (CD 3-6) (NNS experiments)))) (-RRB- -RRB-)))))))) (. .)))
(S1 (S (S (S (VP (VBG Using) (NP (DT the) (JJ same) (NN stimulation) (NN method)))) (, ,) (NP (NN THP-1) (NN reporter) (NNS cells)) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NP (NN Bay11-7082)) (PRN (-LRB- -LRB-) (NP (CD 20) (NN microM)) (-RRB- -RRB-)))) (PP (IN for) (NP (CD 1) (NN hour))) (ADVP (ADVP (RB prior)) (PP (TO to) (NP (NP (NN priming)) (PP (IN with) (NP (NP (JJ heat-killed) (NNS PAO1)) (CC or) (NP (JJ live) (NNS PAO1)))))))))) (. .)))
(S1 (S (S (NP (NNS Supernatants)) (VP (VBD were) (VP (VBN assayed) (PP (IN at) (NP (CD 24) (NNS hours))) (PP (IN for) (NP (NP (LST (-LRB- -LRB-) (LS D) (-RRB- -RRB-)) (NN NF-kappaB/AP-1) (NN activity)) (, ,) (NP (-LRB- -LRB-) (NN E) (-RRB- -RRB-) (NN IL-8)) (, ,) (CC and) (NP (NP (-LRB- -LRB-) (NN F) (-RRB- -RRB-) (NN IL-1beta) (NN secretion)) (PRN (-LRB- -LRB-) (NP (NN n) (JJ =) (CD 3-5)) (-RRB- -RRB-)))))))) (. .)))
(S1 (S (S (NP (NP (NNS PBMCs)) (PP (IN from) (NP (NP (NP (NN CF) (NNS patients)) (PRN (-LRB- -LRB-) (NP (NN n) (JJ =) (CD 11-15)) (-RRB- -RRB-))) (CC and) (NP (NP (NNS controls)) (PRN (-LRB- -LRB-) (NP (NN n) (JJ =) (CD 10-13)) (-RRB- -RRB-)))))) (VP (VBD were) (VP (VP (VBN treated) (PP (IN with) (NP (NP (NP (NN z-YVAD-fmk)) (PRN (-LRB- -LRB-) (NP (CD 20) (NN microM)) (-RRB- -RRB-))) (CC or) (NP (NP (NN Bay11-7082)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN microM)) (-RRB- -RRB-)))))) (CC and) (VP (VBN stimulated) (PP (IN with) (NP (NP (NP (JJ live) (NN PAO1)) (PRN (-LRB- -LRB-) (NP (NN MOI) (JJ =) (CD 1)) (-RRB- -RRB-))) (, ,) (NP (NP (NN ATP)) (PRN (-LRB- -LRB-) (NP (CD 5) (NN mM)) (-RRB- -RRB-))) (, ,) (CC or) (NP (NP (NN Poly-LRB-dA:dT-RRB-)) (PRN (-LRB- -LRB-) (NP (CD 1) (NN microg/ml)) (-RRB- -RRB-))))) (PP (VBG according) (PP (TO to) (NP (NP (DT the) (NN schedule)) (PP (IN in) (NP (NN Figure) (CD 1)))))))))) (. .)))
(S1 (S (S (NP (NP (NP (-LRB- -LRB-) (NN G) (-RRB- -RRB-) (NN IL-1beta)) (CC and) (NP (-LRB- -LRB-) (NN H) (-RRB- -RRB-) (NN IL-8))) (NNS levels)) (VP (VBD were) (VP (VBN measured) (PP (IN at) (NP (CD 24) (NNS hours)))))) (. .)))
(S1 (S (S (NP (JJ Statistical) (NN analysis)) (VP (VBD was) (VP (VBN performed) (S (VP (VBG using) (NP (NP (CD two) (NN way) (NN ANOVA)) (PP (IN with) (NP (NNP Bonferroni) (NN correction))) (PP (IN for) (NP (JJ multiple) (NNS comparisons))))))))) (. .)))
(S1 (S (S (NP (NP (NN *)) (, ,) (NP (NN **)) (, ,) (CC and) (NP (NN ***))) (VP (VBP signify) (NP (NP (NN P) (NN <) (CD 0.05)) (, ,) (NP (CD 0.01)) (, ,) (CC and) (NP (CD 0.001))))) (. .)))
